NovAccess Global Inc.: NovAccess Global Announces Uplisting to OTCQB

CLEVELAND, OH / ACCESSWIRE / August 10, 2022 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced that the trading of its

Related Keywords

Dwaink Irvin , ,Securities Exchange Commission ,Novaccess Inc ,Darrow Associates ,Securities Exchange ,Our Company ,Novaccess Global Inc ,Novaccess Global ,Exchange Commission ,Chief Executive Officer ,Access Global ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Relations Contact ,Novaccess ,Lobal ,Nnounces ,Uplisting ,Tcqb ,